FDA Investigator Katelyn Astaub Zamperini
Katelyn Astaub Zamperini has conducted inspections on 250 sites in 8 countries as of 15 Mar 2022. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
250
Last Inspection Date:
15 Mar 2022
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Italy,
Ireland,
Germany,
Korea (Republic of),
Switzerland,
Canada,
Dominican Republic
FDA Investigators that have inspected at least one site in common with Katelyn Astaub Zamperini:
Akbar J Zaidi,
Alison N Stieg,
Althea A Williams,
Amber M Capello Jones,
Anastasia I Onuorah,
Andrew J Garufi,
Ann Marie Karnick,
Atul J Agrawal,
Benjamin J Dastoli,
Brandi L Garbutt,
Brandon J Brookens,
Brandon M Kurjanowicz,
Brian M Palermo,
Brooke K Higgins,
Brooke K Seeman,
Carl E Lovrich,
Catherine J Laufmann,
CDR Ileana Barreto Pettit,
Chaltu Nwakijra,
Chamberlain,
Christina L Bigham,
Christine I Shaw,
Crayton Lee,
Cynthia A Harris, MD, RN,
Cynthia L Rakestraw,
Cynthia T Cain,
Daniel J Mechenbier,
Daniel R Tammariello,
Dauksism,
David J Gasparovich,
David J Hafner,
Dennis L Doupnik,
Dennis R Hock,
Dessa A Antoine,
Diane T Bargo,
Diane T O'brien,
Dolores Harper,
Douglas A Campbell,
Elizabeth B Griffin,
Emest F Bizjak,
Erica L Nicoll,
Erika M Wilkerson,
Erin L Mcfiren,
Gale L Glinecki,
Gladys B Casper,
Gregory E Beichner,
Gregson A Joseph,
Guerlain Ulysse,
Heika R Tait,
Hilary K Wagner,
Iqra Iftikhar,
Iris C Macinnes,
Jacob M Dyer,
James D Hildreth,
James M Mason,
James M Odonnell,
James M Simpson,
James P Mcevoy,
James W Leonette,
Janet A Rajan,
Janet B Abt,
John E Marszalek,
John P Mistler,
Johnna L Bleem,
Jonathan W Chapman,
Joseph R Hatcher,
Joshua E Yao,
Joshua J Silvestri,
Juliana M Badalucco,
Karen A Spencer,
Katarzyna Plona,
Katlin N Stubbs,
Kirk A Dymbrowski,
Ko U Min,
Kshitij A Patkar,
Laureen M Geniusz,
Lawrence J Stringer,
LCDR Margaret Edi Gennaro,
LCDR Susan E Polifko,
LCDR William H Bender,
Leo J Lagrotte,
Leslie R Clark,
Lindsey L Kirsh,
LT John M Mastalski,
Luis A Dasta,
Marc S Neubauer,
Marcus A Ray,
Maribeth G Niesen,
Marjorie L Davis,
Mary E Storch,
Mary R Kirker,
Massoud Motamed,
Melanie G Warzala,
Melanie W Pishnery,
Melissa J Garcia,
Melissa T Roy,
Meredith L Sheridan,
Michael A Taylor,
Michael J Diskin,
Michael R Klapal,
Michael S Call,
Michelle Marsh,
Myrick,
Nancy E Byerly,
Nancy M Espinal,
Nikisha M Bolden,
Nisha C Patel,
Patricia A Mcilroy,
Paula J Bretz,
Phillip M Pontikos,
Pratik S Upadhyay, DDC,
Qin Xu,
Rabin N Ghoshal,
Rebecca Clark,
Rebecca E Dombrowski,
Rene R Ramirez,
Robert E Davis,
Rosanna M Goodrich,
Rosanna M Vaccaro,
Sean D Duke,
Sean R Marcsisin,
Sean Y Kassim, PhD,
Shannon A Gregory,
Shelley L Waring,
Sneha S Patel,
Sony Mathews,
Stephanie Mangigian, MS/OSH, RN,
Steven R Ziser,
Syeda N Mahazabin,
Tamara S Rosbury,
Tamika White,
Tamil Arasu, PhD,
Tammy M Phillips,
Tara M Aikens,
Teresa K Kastner,
Terry C Kimball,
Thai T Duong,
That Q Dang,
Thomas J Arista,
Thomas R Withers,
Tiki J Dixon,
Timothy J Schmidt,
Toyin B Oladimeji,
Travis R Hunt,
Van Cliff,
William A Warnick,
William C Brenneman,
William D Bassett, Jr,
William L Bargo,
William R Chang,
Xiaojun Yan
Katelyn Astaub Zamperini's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more